Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Pachytene Stage
Identification of cytotoxic T cells and their T cell receptor sequences targeting COVID-19 using MHC class I-binding peptides.
Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms.
Zhang, Linghuan
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2019 04 01; 25(7):2305-2313.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers
Cell Line, Tumor
Cell Survival
Dopamine D2 Receptor Antagonists
Drug Resistance
Gene Expression
Humans
Imidazoles
Immunohistochemistry
Magnetic Resonance Imaging
Neoplasm Grading
Neoplasm Staging
Neoplasms
Prognosis
Protein Binding
Pyridines
Pyrimidines
Receptors, Dopamine D2
Receptors, Dopamine D5
Signal Transduction
authors with profiles
Deric Park